Stocks
IGM Biosciences (IGMS) ROE US GAAP (year values) |
||||||||
| FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | LTM ? | |||
| ROE, % | ? | 42.6% | 45.4% | 37.3% | -121.2% | -406.4% | -52.9% | |
| Changes by years, y/y, % | +3pp | +3pp | -8pp | -159pp | -285pp | |||
IGM Biosciences. ROE, %
IGM Biosciences. ROE, changes, pp
IGM Biosciences (IGMS) ROE US GAAP (quarter values) |
||||||||
| FY2024Q2 | FY2024Q3 | FY2024Q4 | FY2025Q1 | FY2025Q2 | LTM ? | |||
| ROE, % | ? | -180.1% | -278.5% | -406.4% | -28 492% | -52.9% | -52.9% | |
| Changes by years, y/y, % | -92pp | -186pp | -285pp | -28 345pp | +127pp | |||
| Changes by quarters, q/q, % | -33pp | -98pp | -128pp | -28 085pp | +28 439pp | |||
